Treatment of steroid-resistant acute graft-vs-host disease by in vivo administration of an anti-T-cell ricin A chain immunotoxin
- 3 June 1988
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 259 (21), 3154-3157
- https://doi.org/10.1001/jama.259.21.3154
Abstract
Research from JAMA — Treatment of Steroid-Resistant Acute Graft-vs-host Disease by In Vivo Administration of an Anti—T-Cell Ricin A Chain ImmunotoxinThis publication has 16 references indexed in Scilit:
- Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin.The Journal of Immunology, 1984
- EX-VIVO TREATMENT OF DONOR BONE MARROW WITH ANTI-T-CELL IMMUNOTOXINS FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASEThe Lancet, 1984
- HIGH-DOSE METHYLPREDNISOLONE TREATMENT FOR ACUTE GRAFT-VERSUS-HOST DISEASE AFTER BONE MARROW TRANSPLANTATION IN ADULTSTransplantation, 1984
- MONOCLONAL-ANTIBODY THERAPEUTIC TRIALS IN 7 PATIENTS WITH T-CELL LYMPHOMA1983
- Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia.The Journal of Experimental Medicine, 1982
- Treatment of graft‐versus‐host disease in human allogeneic marrow graft recipients: A randomized trial comparing antithymocyte globulin and corticosteroidsAmerican Journal of Hematology, 1981
- SEROTHERAPY OF ACUTE LYMPHOBLASTIC-LEUKEMIA WITH MONOCLONAL-ANTIBODY1981
- Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin.Proceedings of the National Academy of Sciences, 1980
- Gelonin, a new inhibitor of protein synthesis, nontoxic to intact cells. Isolation, characterization, and preparation of cytotoxic complexes with concanavalin A.Journal of Biological Chemistry, 1980
- DOES GRAFT VERSUS HOST DISEASE INFLUENCE TEMPO OF IMMUNOLOGICAL RECOVERY AFTER ALLOGENEIC HUMAN MARROW TRANSPLANTATION - OBSERVATION ON 56 LONG-TERM SURVIVORS1978